BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1906344)

  • 1. Transcriptional deregulation of myc in IgH/myc 6;7 translocation carrying rat immunocytomas.
    Axelson H; Pear WS; Panda CK; Bazin H; Klein G; Sümegi J
    Genes Chromosomes Cancer; 1991 Mar; 3(2):142-8. PubMed ID: 1906344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
    Madisen L; Groudine M
    Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three exceptional IgH/myc-translocation-carrying rat immunocytomas have breakpoints 50 to 80 kb 5' of c-myc.
    Axelson H; Panda CK; Klein G
    Int J Cancer; 1994 Feb; 56(3):418-21. PubMed ID: 8314330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6;7 chromosomal translocation in spontaneously arising rat immunocytomas: evidence for c-myc breakpoint clustering and correlation between isotypic expression and the c-myc target.
    Pear WS; Wahlström G; Nelson SF; Axelson H; Szeles A; Wiener F; Bazin H; Klein G; Sümegi J
    Mol Cell Biol; 1988 Jan; 8(1):441-51. PubMed ID: 3122026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
    Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
    J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC.
    Zeidler R; Joos S; Delecluse HJ; Klobeck G; Vuillaume M; Lenoir GM; Bornkamm GW; Lipp M
    Genes Chromosomes Cancer; 1994 Apr; 9(4):282-7. PubMed ID: 7519050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant class switching juxtaposes c-myc with a middle repetitive element (LINE) and an IgH intron in two spontaneously arising rat immunocytomas.
    Pear WS; Nelson SF; Axelson H; Wahlström G; Bazin H; Klein G; Sümegi J
    Oncogene; 1988 May; 2(5):499-507. PubMed ID: 3131719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
    Müller JR; Janz S; Potter M
    Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple chromosomal rearrangements in a spontaneously arising t(6;7) rat immunocytoma juxtapose c-myc and immunoglobulin heavy chain sequences.
    Pear WS; Ingvarsson S; Steffen D; Münke M; Francke U; Bazin H; Klein G; Sümegi J
    Proc Natl Acad Sci U S A; 1986 Oct; 83(19):7376-80. PubMed ID: 3020544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
    Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
    Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of MYC overexpression in pediatric Burkitt's lymphoma is strongly dependent on genomic breakpoint location within the MYC locus.
    Wilda M; Busch K; Klose I; Keller T; Woessmann W; Kreuder J; Harbott J; Borkhardt A
    Genes Chromosomes Cancer; 2004 Oct; 41(2):178-82. PubMed ID: 15287031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allele-specific activation of the c-myc gene in an atypical Burkitt's lymphoma carrying the t(2;8) chromosomal translocation 250 kb downstream from c-myc.
    Tachibana K; Takayama N; Matsuo K; Kato S; Yamamoto K; Ohyama K; Umezawa A; Takano T
    Gene; 1993 Feb; 124(2):231-7. PubMed ID: 8444346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
    Busch K; Keller T; Fuchs U; Yeh RF; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
    Leukemia; 2007 Aug; 21(8):1739-51. PubMed ID: 17541401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb.
    Joos S; Falk MH; Lichter P; Haluska FG; Henglein B; Lenoir GM; Bornkamm GW
    Hum Mol Genet; 1992 Nov; 1(8):625-32. PubMed ID: 1301171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The amino-terminal phosphorylation sites of C-MYC are frequently mutated in Burkitt's lymphoma lines but not in mouse plasmacytomas and rat immunocytomas.
    Axelson H; Henriksson M; Wang Y; Magnusson KP; Klein G
    Eur J Cancer; 1995 Nov; 31A(12):2099-104. PubMed ID: 8562172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda.
    Axelson H; Panda CK; Silva S; Sugiyama H; Wiener F; Klein G; Sumegi J
    Oncogene; 1991 Dec; 6(12):2263-70. PubMed ID: 1766673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of immunoglobulin kappa elements in c-myc activation.
    Hörtnagel K; Mautner J; Strobl LJ; Wolf DA; Christoph B; Geltinger C; Polack A
    Oncogene; 1995 Apr; 10(7):1393-401. PubMed ID: 7731690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
    Jain VK; Judde JG; Max EE; Magrath IT
    J Immunol; 1993 Jun; 150(12):5418-28. PubMed ID: 8515068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.